The first potent and selective non-imidazole human histamine H4 receptor antagonists.
Jill A Jablonowski, Cheryl A Grice, Wenying Chai, Curt A Dvorak, Jennifer D Venable, Annette K Kwok, Kiev S Ly, Jianmei Wei, Sherry M Baker, Pragnya J Desai, Wen Jiang, Sandy J Wilson, Robin L Thurmond, Lars Karlsson, James P Edwards, Timothy W Lovenberg, Nicholas I Carruthers
Index: J. Med. Chem. 46 , 3957-3960, (2003)
Full Text: HTML
Abstract
Following the discovery of the human histamine H4 receptor, a high throughput screen of our corporate compound collection identified compound 6 as a potential lead. Investigation of the SAR resulted in the discovery of novel compounds 10e and 10l, which are the first potent and selective histamine H4 receptor antagonists to be described.
Related Compounds
Related Articles:
2015-05-01
[Microcirculation 22 , 237-48, (2015)]
2014-08-01
[Br. J. Pharmacol. 171(15) , 3754-63, (2014)]
Analysis of the histamine H2-receptor in human monocytes.
2014-11-15
[Biochem. Pharmacol. 92(2) , 369-79, (2014)]
2010-01-01
[Respir. Res. 11 , 86, (2010)]
Ligand Residence Time at G-protein-Coupled Receptors-Why We Should Take Our Time To Study It.
2015-09-01
[Mol. Pharmacol. 88 , 552-60, (2015)]